期刊文献+

Inhibitory Effects of Parthenolide on the Angiogenesis Induced by Human Multiple Myeloma Cells and the Mechanism 被引量:3

Inhibitory Effects of Parthenolide on the Angiogenesis Induced by Human Multiple Myeloma Cells and the Mechanism
下载PDF
导出
摘要 The inhibitory effects of parthenolide (PTL) on angiogenesis induced by multiple myeloma (MM) cells in vitro and the mechanism were investigated. Human MM line RPMI8226 cells were cultured in vitro. The effects of MM culture supernatant on the migration and tubule formation ability of human umbilical vein endothelial cells (HUVECs) treated with PTL were observed. By using Western blot, the expression of p65 and IкB-α in MM cells was detected. RT-PCR was used to assay the expression of VEGF, IL-6, MMP2 and MMP9 mRNA in MM cells. ELISA was used to measure the levels of VEGF and IL-6 in MM cell culture supernatant. The expression of MMP2 and MMP9 in MM cells was examined by immunohistochemistry. (1) In 3.5, 5.0, 7.5 and 10 μmol/L PTL groups the number of migrated cells was 310±56, 207±28, 127±21 and 49±10 respectively, which was significantly different from that in positive control group (598±47) (P〈0.01). In 3.5 and 5.0 μmol/L PTL groups the areas of capillary-like structures were 0.092±0.003 and 0.063±0.002 mm2, significantly less than in positive control group (0.262±0.012 mm2) (P〈0.01), but in 7.5 and 10 μmol/L PTL groups no capillary-like structures were found; (2) After treatment with different concentrations of PTL for 48 h, the expression of p65 protein was gradually decreased, while that of IкB-α was gradually enhanced with the increased concentration of PTL; (3) After treatment with 3.5, 5.0, 7.5 and 10 μmol/L PTL for 48 h, the VEGF levels in the supernatant were 2373.4±392.2, 1982.3±293.3, 1247.0±338.4 and 936.5±168.5 pg/mL respectively, significantly different from those in positive control group (2729±440.0 pg/mL) (P〈0.05). After treatment with 7.5 and 10 μmol/L PTL, the IL-6 levels in the culture supernatant were 59.6±2.8 and 41.4±9.8 pg/mL respectively, signifi- cantly lower than in positive control group (1287.3±43.5 pg/mL) (P〈0.05); (4) RT-PCR revealed that PTL could significantly inhibit the expression of VEGF and IL-6 mRNA in MM cells, but not influence the expression of MMP2 and MMP9 mRNA.; (5) Immunohistochemistry indicated that PTL had no significant effects on the expression of MMP2 and MMP9 protein in MM cells. It was concluded that the abilities of the culture supernatant of MM cells treated with PTL to induce endothelial cells migration and tubule formation were significantly reduced, suggesting PTL could obviously inhibit the angiogenesis induced by MM cells. PTL could decrease NF-kappaB activity and significantly suppress the expression of VEGF and IL-6 mRNA and protein, which might contribute to the mechanism by which PTL inhibited the angiogenesis induced by MM cells. The inhibitory effects of parthenolide (PTL) on angiogenesis induced by multiple myeloma (MM) cells in vitro and the mechanism were investigated. Human MM line RPMI8226 cells were cultured in vitro. The effects of MM culture supernatant on the migration and tubule formation ability of human umbilical vein endothelial cells (HUVECs) treated with PTL were observed. By using Western blot, the expression of p65 and IкB-α in MM cells was detected. RT-PCR was used to assay the expression of VEGF, IL-6, MMP2 and MMP9 mRNA in MM cells. ELISA was used to measure the levels of VEGF and IL-6 in MM cell culture supernatant. The expression of MMP2 and MMP9 in MM cells was examined by immunohistochemistry. (1) In 3.5, 5.0, 7.5 and 10 μmol/L PTL groups the number of migrated cells was 310±56, 207±28, 127±21 and 49±10 respectively, which was significantly different from that in positive control group (598±47) (P〈0.01). In 3.5 and 5.0 μmol/L PTL groups the areas of capillary-like structures were 0.092±0.003 and 0.063±0.002 mm2, significantly less than in positive control group (0.262±0.012 mm2) (P〈0.01), but in 7.5 and 10 μmol/L PTL groups no capillary-like structures were found; (2) After treatment with different concentrations of PTL for 48 h, the expression of p65 protein was gradually decreased, while that of IкB-α was gradually enhanced with the increased concentration of PTL; (3) After treatment with 3.5, 5.0, 7.5 and 10 μmol/L PTL for 48 h, the VEGF levels in the supernatant were 2373.4±392.2, 1982.3±293.3, 1247.0±338.4 and 936.5±168.5 pg/mL respectively, significantly different from those in positive control group (2729±440.0 pg/mL) (P〈0.05). After treatment with 7.5 and 10 μmol/L PTL, the IL-6 levels in the culture supernatant were 59.6±2.8 and 41.4±9.8 pg/mL respectively, signifi- cantly lower than in positive control group (1287.3±43.5 pg/mL) (P〈0.05); (4) RT-PCR revealed that PTL could significantly inhibit the expression of VEGF and IL-6 mRNA in MM cells, but not influence the expression of MMP2 and MMP9 mRNA.; (5) Immunohistochemistry indicated that PTL had no significant effects on the expression of MMP2 and MMP9 protein in MM cells. It was concluded that the abilities of the culture supernatant of MM cells treated with PTL to induce endothelial cells migration and tubule formation were significantly reduced, suggesting PTL could obviously inhibit the angiogenesis induced by MM cells. PTL could decrease NF-kappaB activity and significantly suppress the expression of VEGF and IL-6 mRNA and protein, which might contribute to the mechanism by which PTL inhibited the angiogenesis induced by MM cells.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2008年第5期525-530,共6页 华中科技大学学报(医学英德文版)
基金 a grant from Hubei Natural Sciences Foundation of China (No. 2007ABA027)
关键词 wparthenolide multiple myeloma ANGIOGENESIS NF-kappaB activity VEGF IL-6 MMPS wparthenolide multiple myeloma angiogenesis NF-kappaB activity VEGF IL-6 MMPs
  • 相关文献

参考文献12

  • 1陈智超,李秋柏,邵菁,吕建,游泳,仲照东,邹萍.小白菊内酯对多发性骨髓瘤细胞的生长抑制及其凋亡诱导作用[J].中华医学杂志,2006,86(28):1993-1996. 被引量:12
  • 2张蕾,陈世伦,陈文明,刘晋伟.多发性骨髓瘤血管内皮生长因子和白细胞介素-6相互作用的研究[J].中华内科杂志,2005,44(2):85-88. 被引量:11
  • 3Song X K,Pan F J.Biological activity of parthenolilde and NF-kappa B channel inhibition[].Chin J Gerontol.2003
  • 4San Miguel J F,,Blade Creixenti J,Garcia-Sanz R.Treat-ment of multiple myeloma[].Haematologica.1999
  • 5Lemoli R M,Martinelli G,Zamagni E et al.Engraftment,clinical,and molecular follow-up of patients with multi-ple myeloma who were reinfused with highly purified CD34+cells to support single or tandem high-dose che-motherapy[].Blood.2000
  • 6Vacca A,Ribatt i D,Presta M et a1.Bone marrow ne-ovascularization.Plasma cell angiogenic potential and matrix metalloproteinase-2secretion parallel progression of human multiple myeloma[].Blood.1999
  • 7Martinelli G,Terragna C,Zamagni E,et al.Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma[].Journal of Clinical Oncology.2000
  • 8Cavo,M,Terragna,C,Martinelli,G.Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma[].Blood.2000
  • 9Folkman J.Clinical applications of research on angiogenesis[].The New England Journal of Medicine.1995
  • 10Folkman J.New perspectives in clinical oncology from angiogenesis research[].European Journal of Cancer.1996

二级参考文献19

  • 1Ma Z, Otsuyama KI, Liu SQ, et al. Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang ( HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. Blood, 2005,105:3312-3318.
  • 2Kim JH, Liu L, Lee SO, et al. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis. Cancer Res, 2005, 65:6312-6320.
  • 3Park JH, Liu L, Kim IH, et al. Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells. Cancer Res,2005, 65:2804-2814.
  • 4Monica LG, Randall MR, Lilliana K, et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood, 2005,105:4163-4169.
  • 5Steffen PH, Thomas GH, Wulf D, et al. The antiinflammatory sesquiterpene laetone parthenolide inhibits NF-B by targeting the IB kinase complex. J Immunol, 1999,163: 5617.
  • 6Anderson K. Advances in the biology of multiple myeloma:therapeutic applications. Semin Oncol,1999,26:10-22.
  • 7Hideshima T, Chauhan D, Richardson P, et al. NF-KB as at herapeutic target in multiple myeloma. J Biol Chem, 2002, 277:16639-16647.
  • 8Hideshima T, Mitsiades C, Akiyama M, et al. Molecular mechanisms mediating antimyeloma activity of proteosome inhibitor PS-341. Blood, 2003,101 : 1530-1534.
  • 9Bellamy WT. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies.Semin Oneol, 2001, 28: 551-559.
  • 10Dankbar B, Padre T, Leo R, et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell in teractions inmultiple myeloma. Blood, 2000, 95 : 2630-2636.

共引文献21

同被引文献7

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部